141 related articles for article (PubMed ID: 13366694)
1. Progress report of American Diabetes Association on orally effective hypoglycemic sulfonylureas.
COLWELL AR; INGLE D; KRAHL ME; LEVINE R; RICKETTS HT
J Am Med Assoc; 1956 Nov; 162(10):976-7. PubMed ID: 13366694
[No Abstract] [Full Text] [Related]
2. The mechanism of action of the sulfonylureas in diabetes mellitus.
LEVINE R; SOBEL GW
Diabetes; 1957; 6(3):263-9. PubMed ID: 13427633
[No Abstract] [Full Text] [Related]
3. Clinical studies on the hypoglycaemic action of the sulphonylureas.
BUTTERFIELD WJ; CAMP JL; HARDWICK C; HOLLING HE
Lancet; 1957 Apr; 272(6972):753-6. PubMed ID: 13417585
[No Abstract] [Full Text] [Related]
4. Current status of aryl sulfonylureas in treatment of diabetes mellitus.
DAVIDSON JW; UNGER RH
J Am Med Assoc; 1956 Sep; 162(5):447-53. PubMed ID: 13357329
[No Abstract] [Full Text] [Related]
5. Sulfonylureas and diabetes mellitus. I. Clinical evaluation.
COX RW; FERGUS EB; HENLEY ED; WILLIAMS RH
Diabetes; 1956; 5(5):358-65. PubMed ID: 13365475
[No Abstract] [Full Text] [Related]
6. CURRENT investigation of the hypoglycemic action of sulfonylureas.
Nutr Rev; 1957 May; 15(5):150-1. PubMed ID: 13431090
[No Abstract] [Full Text] [Related]
7. Present state of knowledge concerning effects of the sulfonylurea compounds in diabetes mellitus; report of the Committee on Summarization of the Conference.
KRAHL ME; LUKENS FD; RICKETTS HT
Diabetes; 1957; 6(1):91-2. PubMed ID: 13397436
[No Abstract] [Full Text] [Related]
8. Observations with sulfonylureas in diabetes.
BROWN FR; FRISKEY RW; KINSELL LW; MICHAELS GD
Metabolism; 1956 Nov; 5(6 Part 2):864-7. PubMed ID: 13378055
[No Abstract] [Full Text] [Related]
9. Clinical experiences with carbutamide, an orally given hypoglycemic agent; preliminary report.
RIDOLFO AS; KIRTLEY WR
J Am Med Assoc; 1956 Apr; 160(15):1285-8. PubMed ID: 13306540
[No Abstract] [Full Text] [Related]
10. The hypoglucemic sulfonylurea drugs; an interim evaluation.
STETTEN D
Ann Intern Med; 1957 May; 46(5):1005-8. PubMed ID: 13411912
[No Abstract] [Full Text] [Related]
11. [Experiences on 1,000 diabetics treated with sulfonylureas (BZ 55 and D 860)].
BERTRAM F
Gaz Med Fr; 1957 Mar; 64(6):519-24. PubMed ID: 13427958
[No Abstract] [Full Text] [Related]
12. Observations in diabetic subjects treated with sulfonylurea compounds.
BROWN F; FRISKEY R; KINSELL LW; SPLITTER TS; TALPERS SJ
Diabetes; 1957; 6(1):64-7; discussion, 85-90. PubMed ID: 13397428
[No Abstract] [Full Text] [Related]
13. Studies of the mechanism of action of sulfonylurea derivatives.
GOLDNER MG; LAZARUS SS; VOLK BW; WEISENFELD S
Diabetes; 1957; 6(1):53-4. PubMed ID: 13397423
[No Abstract] [Full Text] [Related]
14. Effects of sulfonylurea drugs in hospitalized diabetic patients.
RICKETTS HT; WILDBERGER HL
Diabetes; 1957; 6(1):62-4; discussion, 85-90. PubMed ID: 13397427
[No Abstract] [Full Text] [Related]
15. Effects of sulfonylurea drugs in hospitalized diabetic patients.
RICKETTS HT; WILDBERGER HL
J Am Med Assoc; 1956 Nov; 162(11):1045-9. PubMed ID: 13366706
[No Abstract] [Full Text] [Related]
16. Hypoglycemic sulfonylureas in various types of experimental diabetes.
BUSE JF; GORDON MF; LUKENS FD
Diabetes; 1957; 6(1):7-12; discussion, 19-20. PubMed ID: 13397410
[No Abstract] [Full Text] [Related]
17. The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus.
DIENGOTT D; DOLGER H; MIRSKY IA
Metabolism; 1956 Nov; 5(6 Part 2):875-93. PubMed ID: 13378057
[No Abstract] [Full Text] [Related]
18. ORAL HYPOGLYCEMIC agents.
Nutr Rev; 1956 Jul; 14(7):203-4. PubMed ID: 13335036
[No Abstract] [Full Text] [Related]
19. Hypoglycaemic sulphonamides in the management of diabetes mellitus.
DOWNIE E; BORNSTEIN J; HUDSON B
Australas Ann Med; 1957 May; 6(2):105-12. PubMed ID: 13445634
[No Abstract] [Full Text] [Related]
20. Hypoglycaemic sulphonamides in treatment of diabetes.
WALKER G; LEESE WL; NABARRO JD
Br Med J; 1956 Aug; 2(4990):451-2. PubMed ID: 13342511
[No Abstract] [Full Text] [Related]
[Next] [New Search]
